Magaldrate + Simethicone Suspension
Magaldrate IP 480mg + Simethicone IP 20mg Oral Suspension · Antacids, Gastroenterology, General Wellness
WHO-GMP
DCGI Approved
Baddi, HP
Active Pharma Composition
SUSPENSION PRESENTATION (480mg + 20mg):
Each 5 ml contains:
Magaldrate IP
480 mg
Simethicone IP
20 mg
Flavoured Suspension Base
q.s.
SUSPENSION PRESENTATION (540mg + 50mg):
Each 5 ml contains:
Magaldrate IP
540 mg
Simethicone IP
50 mg
Flavoured Suspension Base
q.s.
Product Data Sheet
Segments & Ranges
Suspensions / Oral Liquids
Dosage Form
Oral Suspension
Pharma Class
Antacids / Gastroenterology / General Wellness
Pack Sizes
170 ml
Storage Condition
Store below 30°C in a cool, dry place. Protect from direct sunlight. Do not freeze. Shake well before every use.
Stability / Shelf Life
24 Months
Manufacturing Location
Baddi, Himachal Pradesh
Compliance
DCGI Approved / Schedule M
Available Strengths
Magaldrate 480mg + Simethicone 20mg | Magaldrate 540mg + Simethicone 50mg per 5ml
Flavor Options
Mint — the most commercially successful flavour for antacid suspensions in India
Pack Options
170ml — sticker label, metallic label, measuring cap, bell cap, printed cap, with/without carton, sleeve pack
Batch Size
5,000 to 2,00,000+ Units
Schedule M Compliant
Private Label Ready
Pan-India Dispatch
WHO-GMP
ISO 9001:2015
GLP Certified
DCGI Approved
Schedule M
Product Profile
Magaldrate + Simethicone Suspension is a clinically established, non-systemic antacid and anti-flatulent formulation indicated for hyperacidity, heartburn, and gas-related discomfort. As a premier WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech manufactures this suspension with validated two-API quality control and precise rheological control, ensuring reliable antacid performance in every 5ml dose.
DCGI Approved
Comprehensive documentation and CDSCO support for rapid market entry in India.
Fast Turnaround
30-45 days lead time for new batches with state-of-the-art logistics.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Description & Therapeutic Class
Magaldrate + Simethicone Suspension belongs to the Suspensions category within the Antacids and Gastroenterology therapeutic segments. This combination addresses both acid-related symptoms and gas-related discomfort.
- Magaldrate 480mg/540mg — a unique hydroxy-magnesium aluminate with rapid and sustained acid neutralisation
- Simethicone 20mg/50mg — an anti-flatulent that reduces gas bubble surface tension
For pharmaceutical marketing companies, this is a high-volume antacid product with consistent year-round demand. Saar Biotech manufactures it from our manufacturing facility in Baddi with validated two-API suspension quality control.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
The Saar Biotech Advantage
At Saar Biotech, we manufacture Magaldrate + Simethicone Suspension using a controlled oral suspension manufacturing process that ensures dose uniformity, palatability, and packaging reliability.
- Two-API Suspension Uniformity: Both Magaldrate and Simethicone must be uniformly distributed. Our high-shear mixing and validated fill procedures ensure dose-to-dose consistency.
- Taste Masking: Mint-flavoured suspension bases effectively mask the chalky taste of Magaldrate.
- pH and Stability Management: Both actives remain chemically stable for 24 months under tropical storage conditions.
- 170ml Pack Coverage: From dark amber bottles to measuring caps and bell caps — our packaging options help antacid brands stand out.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Key Indications & Clinical Use
Magaldrate + Simethicone Suspension is manufactured and supplied by Saar Biotech for the following established clinical indications:
- Hyperacidity: Rapid and sustained relief from excess stomach acid
- Heartburn: Relief from burning sensation associated with acid reflux
- Acid Indigestion: Management of post-prandial acid-related discomfort
- Gastritis: Symptomatic relief from gastric inflammation
- Flatulence: Relief from gas, bloating, and abdominal discomfort
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Mechanism of Action & Manufacturing Integrity
Two-Component Clinical Mechanism
Magaldrate is a hydroxy-magnesium aluminate that reacts with gastric hydrochloric acid to form aluminium hydroxide, magnesium hydroxide, and water. It provides rapid acid neutralisation with sustained action, maintaining gastric pH in the therapeutic range without causing systemic alkalosis.
Simethicone reduces the surface tension of gas bubbles in the gastrointestinal tract, facilitating their coalescence and expulsion, providing relief from bloating and discomfort.
Manufacturing Integrity
- Two-API Suspension Uniformity: Both actives must be uniformly distributed. Our suspending agent system ensures consistent dispersion.
- pH and Stability Management: The suspension vehicle is pH-buffered to maintain both actives’ chemical stability.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Pharmacokinetics & B2B Commercial Value
- Rapid Onset: Magaldrate provides immediate acid neutralisation.
- Non-Systemic: Not significantly absorbed, reducing systemic side effects.
- Consistent Year-Round Demand: Antacids are among the highest-frequency repurchase pharmaceutical products.
- 170ml Pack Logic: The 170ml format is ideal for standard treatment courses.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
B2B & Contract Manufacturing Details
Saar Biotech provides Third-Party Manufacturing and Contract Manufacturing for Magaldrate + Simethicone Suspension from our dedicated oral suspension manufacturing facility in Baddi, Himachal Pradesh.
- Facility: Oral suspension manufacturing area with controlled processing, automated bottle filling, capping, labelling, and carton packing lines.
- Capacity: Scalable from brand-entry launches to large commercial batches; 64×170ml distributor dispatch configurations available.
- Quality Lab: In-house GLP-certified lab with titrimetric assay, pH, viscosity, MLT, and fill volume checks.
- Turnaround: New orders — 30 to 45 working days. Repeat orders — 20 to 25 working days.
- Packaging: 170ml PET or dark amber bottles; sticker label, metallic label, measuring cup, bell cap, printed cap, with/without carton.
- MOQ: Starting at 5,000–10,000 units per SKU.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Storage & Handling Guidelines
- Warehouse Conditions: Store below 30°C in a cool, dry environment. Do not freeze.
- Shake Well Before Every Dose: Critical for uniform API distribution.
- Measuring Cup Use: A calibrated measuring cup ensures accurate dosing.
- Light Protection: Dark amber bottles and outer cartons protect from light-induced degradation.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Quality Control & Compliance
Every commercial batch is quarantined until it passes a comprehensive analytical release protocol:
- Assay: Titrimetric confirmation of Magaldrate and Simethicone content.
- Suspension Uniformity & Re-Dispersibility: Sediment behaviour and post-shaking uniformity are evaluated.
- pH & Viscosity Testing: The suspension’s pH and flow characteristics are monitored.
- Microbial Limit Testing (MLT): IP-compliant microbiological testing.
- Certificate of Analysis (COA): Issued with every B2B batch.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Safety Profile & Precautions
- Renal Precautions: Caution in patients with renal impairment due to magnesium accumulation risk.
- Drug Interactions: Maintain 2-hour gap with other medications.
- Contraindications: Known hypersensitivity to any component; gastrointestinal obstruction; sodium-restricted diets.
For third-party manufacturing enquiries, private-label contracts, or to request pricing and packaging options for Magaldrate + Simethicone Suspension, please use the B2B enquiry form below.
Pan-India Supply & Contract Manufacturing
Batch Lead Time
30-45 Days (Domestic)
B2B Services
Contract & Third-Party
Compliance
DCGI & Schedule M Standards
Medical Intelligence
Clinical Q&A for Magaldrate + Simethicone Suspension
Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.
What are the clinical indications for Magaldrate + Simethicone Suspension?
This combination suspension is indicated for the symptomatic relief of hyperacidity, heartburn, acid indigestion, gastritis, and flatulence. Magaldrate provides rapid and sustained acid neutralisation without causing systemic alkalosis, while Simethicone reduces gas bubbles in the gastrointestinal tract, providing relief from bloating and discomfort. The combination is effective for both acute and chronic acid-related gastrointestinal conditions.
How does Magaldrate differ from other antacids?
Magaldrate is a unique hydroxy-magnesium aluminate with a high acid-neutralising capacity. Unlike simple aluminium or magnesium hydroxide combinations, Magaldrate provides rapid acid neutralisation with sustained action. Its non-systemic nature means it is not significantly absorbed, reducing the risk of systemic side effects such as alkalosis or electrolyte imbalance commonly associated with sodium-containing antacids.
What is the standard dosing protocol?
The standard adult dose is 5 to 10 ml taken 3 to 4 times daily, 20 minutes to 1 hour after meals and at bedtime, or as directed by a physician. The suspension should be shaken well before each use. The dose should be taken undiluted for maximum effectiveness. Treatment duration should be as prescribed by the physician.
What are the key contraindications and precautions?
This suspension is contraindicated in patients with known hypersensitivity to any component. Caution is advised in patients with renal impairment, as magnesium accumulation may occur. It should be used with caution in patients on sodium-restricted diets and those with gastrointestinal obstruction. Use during pregnancy and lactation should be under physician supervision.
What drug interactions should be considered?
This antacid should be taken at least 2 hours apart from other medications, as it may interfere with the absorption of drugs such as tetracyclines, fluoroquinolones, iron supplements, and levothyroxine. Patients should be counselled to maintain appropriate dosing intervals between this suspension and other oral medications.
Manufacturing Support
B2B Manufacturing Guide for Magaldrate + Simethicone Suspension
Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.
What pack sizes and packaging options are available for Magaldrate Suspension?
Saar Biotech manufactures Magaldrate + Simethicone Suspension in 170 ml bottle formats. The 170 ml pack is the primary commercial format for antacid suspensions. Packaging options include: sticker label, metallic label, measuring cap, bell cap, printed cap, company-logo printed PP cap, with-carton or without-carton supply, and sleeve pack options. Shipper configurations of 64×170ml support distributor-level bulk dispatch.
What is the MOQ for Magaldrate + Simethicone Suspension?
Standard MOQ ranges from 5,000 to 10,000 units per SKU, depending on bottle size, label type, and carton format. Antacids are among the highest-velocity consumer healthcare products in India with consistent year-round demand.
What analytical tests are performed on every manufacturing batch?
Every batch undergoes titrimetric Assay for Magaldrate and Simethicone content verification against IP specifications. Suspension uniformity and re-dispersibility testing ensures dose consistency. pH and viscosity testing confirms suspension stability. Microbial Limit Testing (MLT) meets IP specifications. A Certificate of Analysis (COA) is issued with every B2B consignment.
Does Saar Biotech support brand name registration and DCGI approval?
Yes. Our regulatory team provides end-to-end support for DCGI brand name search and approval for antacid products. We assist partners in verifying that their chosen brand name is available and compliant with DCGI nomenclature guidelines.
What is the turnaround time for a new Magaldrate Suspension order?
Initial third-party production typically requires 30 to 45 working days following packaging confirmation. Consistent repeat commercial orders are swiftly handled within a 20 to 25 working day window.
What is the turnaround time for a new Magaldrate + Simethicone Suspension order?
New third-party antacid suspension orders are dispatched from our oral suspension facility in Baddi within 30 to 45 working days of packaging artwork finalisation. For established gastroenterology brands placing repeat orders, our high-throughput liquid filling lines ensure batch completion within 20 to 25 working days, supporting consistent shelf availability.
Similar Products
Same Formula
Other high-quality products that use the same effective active ingredients.
